Triastek
PrivateLast Round
VC Round
Sep 28, 2023
Est. Valuation
$541M
Total Funding Raised
$80.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Triastek is a pharmaceutical technology company that specializes in innovative 3D printing solutions for the development and production of drug delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triastek Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Triastek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 28, 2023 | ||||
| Series B Extension | Nov 23, 2021 | ||||
| Series B | Jun 24, 2021 | ||||
| Series A | Dec 15, 2020 | ||||
| Series A | Jun 1, 2018 |
Triastek Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B Extension, Series B |
| CPE (CPE Yuanfeng) | Series B |
| Goldmine Multi-family Office | VC Round |
| Tasly Holding Group | Series B |
| Dalton Venture | Series B, Series A |
| Triwise Capital | Series B Extension |
| Morningside Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 218% MoM, from 343 to 1.1K.
Triastek Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triastek's valuation, stock price, and market status.